Episodes: 130
Frequency: Irregular
Rating: 4.4/5.0
Estimated listeners: 100 - 1,000
Gender skew: Male
Listener location: USA
YouTube: 241.0k subscribers
Instagram: 217.0k followers
Publicly listed emails
support@jamanetwork.org
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Cynthia E. Armand, MD - Hosted by Cynthia E. Armand, MD. In this podcast, she interviews authors of articles from JAMA Neurology.
Joseph T. Colonel, PhD - Acoustic Analysis To Screen For Cognitive Impairment In Primary Care Patient–clinician Conversations
Eduardo de Pablo-Fernndez, MD, PhD - Phenoconversion In Pure Autonomic Failure (systematic Review And Meta-analysis)
Alessandra Fanciulli, MD, PhD - Phenoconversion In Pure Autonomic Failure (systematic Review And Meta-analysis)
Susan M. Landau, PhD - Brain Imaging Biomarkers And Cognitive Outcomes In A Multidomain Lifestyle Intervention (pointer Imaging Ancillary Study)
Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk
October 12, 2026
Interview with Anick Bérard, PhD, author of Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk. Hosted by Cynthia Armand, MD. Related Content: Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk
Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease
September 08, 2026
Interview with Prof Zheng-Ming Chen, DPhil author Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease. Hosted by Cynthia E. Armand, MD. Related Content: Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease Exhaled Carbon Monoxide Levels May Offer Clues on the Etiology of Parkinson Disease
Gefurulimab and Generalized Myasthenia Gravis
July 27, 2026
Interview with Kelly G. Gwathmey, MD, author of Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy
Healthy Longevity · Medium booking difficulty · 100 - 1,000 listeners
Brain Matters (Audio) · High booking difficulty · 100 - 1,000 listeners
JAMA Neurology Author Interviews is hosted by Cynthia E. Armand, MD. Its publicly listed email is support@jamanetwork.org. For guest bookings, the host or producer is usually the best person to reach. Podseeker helps you find direct host and producer contacts and pitch from your own inbox.
The publicly listed email for JAMA Neurology Author Interviews: support@jamanetwork.org.
Podseeker estimates JAMA Neurology Author Interviews reaches 100 to 1,000 listeners per episode. Only the publisher has exact numbers.
JAMA Neurology Author Interviews typically books industry leaders. Typical guest background: Neurology/medicine authors with PhD and/or MD degrees, often clinician-scientists; authors of JAMA Neurology articles (including systematic reviews/meta-analyses and imaging/lifestyle intervention studies). Common among recent guests: Authorship of a JAMA Neurology peer-reviewed article; Published clinical or translational neuroscience research; Work spanning biomarkers, imaging, cognitive outcomes, or neurodegenerative/neurologic disorders. Recent guests include Joseph T. Colonel, PhD, Eduardo de Pablo-Fernndez, MD, PhD, and Alessandra Fanciulli, MD, PhD.
High. It mostly books established leaders in its field.
Recent episodes cover Neurology, Neuroscience, Clinical Research, Biomarkers, and Cognitive Impairment. Pitch an idea tied to one of these topics and mention a recent episode.
Publicly listed emails
support@jamanetwork.org
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings